MEDICAL MANAGER

Date: Feb 13, 2026

Location: SAO PAULO, BR

Company: bioconbiolP2

Company Overview

Role Purpose

Department Head-CDMA-Medical Affairs: Plays a pivotal role in leading and overseeing the strategic direction and operational execution of clinical trials within our organization. This role provides guidance to a team of clinical development professionals, ensuring the successful planning, implementation, and management of clinical programs in accordance with regulatory requirements and company objectives.

Academic Stream

MEDICINE AND SURGERY

Work experience (in months)

216

Job Responsibility and key Decisions

Strategic Leadership in Medical Affairs

a Define and execute the medical affairs strategy for Biocon Biologics pipeline and marketed products, ensuring alignment with corporate and regulatory goals.

b Provide strategic direction for scientific communication, evidence generation, and medical education to support commercial and regulatory objectives.

c Lead crossfunctional collaborations with Clinical Development, Regulatory Affairs, Pharmacovigilance, Market Access, and Commercial teams to ensure medical insights drive business strategies.

Scientific Medical Communications

a Oversee the development and dissemination of scientific publications, white papers, conference abstracts, and peerreviewed articles to support the companys biologics portfolio.

b Ensure that all medical content, product dossiers, and promotional materials are scientifically accurate, compliant with regulatory guidelines, and aligned with brand strategy.

c Lead the development of medical training programs for internal teams, including medical science liaisons MSLs, sales teams, and commercial functions.

d Represent Biocon Biologics at scientific conferences, industry forums, and expert advisory boards to enhance scientific engagement.

RealWorld Evidence RWE PostMarketing Studies

a Develop and execute Phase IV studies, observational trials, realworld data RWD studies, and postmarketing surveillance PMS for biosimilars and novel biologics.

b Generate health economics and outcomes research HEOR data to support market access, reimbursement strategies, and payer engagement.

c Drive collaborations with academia, healthcare institutions, and research organizations to generate realworld clinical insights.

Key Opinion Leader KOL Stakeholder Engagement

a Build and maintain strong relationships with global and regional KOLs, investigators, healthcare providers, and patient advocacy groups.

b Organize and lead advisory boards, scientific symposia, and roundtable discussions to gain expert insights and strengthen the scientific reputation of Biocon Biologics.

c Collaborate with healthcare decisionmakers, medical societies, and policymakers to shape the evolving landscape for biosimilars and novel biologics.

Medical Governance Compliance

a Ensure strict compliance with global regulatory guidelines FDA, EMA, CDSCO, PMDA, MHRA and industry best practices ICHGCP, WHO, ISPOR for medical communications and interactions.

b Provide medical review and approval of promotional and nonpromotional materials to ensure compliance with scientific integrity and ethical standards.

c Maintain transparency in medical affairs activities, KOL interactions, and clinical engagement in line with company policies and external regulations.

Medical Training Team Development

a Lead, mentor, and develop a highperforming Medical Affairs team, including Medical Science Liaisons MSLs, scientific affairs professionals, and medical writers.

b Establish training programs and continuous learning initiatives to enhance the scientific expertise of internal teams.

c Drive a culture of innovation, knowledgesharing, and collaboration within the Medical Affairs function.

CrossFunctional Collaboration Business Support

a Work closely with Commercial, Market Access, and Regulatory teams to ensure that medical insights drive business strategies.

b Support the development of medical value dossiers, payer engagement strategies, and health technology assessment HTA submissions.

c Contribute to launch planning and lifecycle management of biosimilars and novel biologics through evidencebased medical strategies.